SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-001146
Filing Date
2018-05-02
Accepted
2018-05-02 09:38:09
Documents
3
Period of Report
2018-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 cannabics_8k.htm 8-K 17843
2 STANDBY EQUITY DISTRIBUTION AGREEMENT cannabics_ex1001.htm EX-10.1 218947
3 PRESS RELEASE cannabics_ex9901.htm EX-99.1 9955
  Complete submission text file 0001683168-18-001146.txt   248086
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 18797816
SIC: 2834 Pharmaceutical Preparations